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a b s t r a c t
Hypothesis: Metallic nanoparticles such as nano-silver have found many applications as alternative anti-
microbials in recent years. However methods for determining their proposed antimicrobial activity have
received little attention to date. The disk diffusion assay is commonly used as a demonstration of antimi-
crobial properties and is a regular feature in synthetic nanoparticle papers. The aim of this study was to
assess its effectiveness in demonstrating the ‘‘nanoparticle specific’’ antimicrobial properties in the
absence of ionic contributions from unreacted reducing agents and or impurities.
Experiments: The disk diffusion assay was carried out on a range of silver nanoparticles, both in-house
synthesised and commercially available, using Escherichia coli ATCC 25922 as a model organism.
Results: Capped and purified nanoparticles show no antimicrobial activity despite claims to the contrary
for this assay. Results will be discussed in terms of the need for researchers without a background in
microbiology to understand the mechanism of antimicrobial action before choosing an assay. Also dis-
cussed is the importance understanding the physiochemical characteristics of when interpreting results.
Finally the relevance of the results in terms establishing protocols for method development for ‘nanopar-
ticle specific’ antimicrobial properties will also be considered.
 2014 Elsevier Inc. All rights reserved.
1. Introduction
The evolution of antibiotic resistant bacteria such as MRSA has
resulted in a significant body of research focused on finding alter-
native antimicrobial agents capable of eradicating these superbugs
[11]. One promising alternative which has been proposed is nano-
silver [23]. Metallic nanoparticles in general have been reported to
have broad spectrum activity against both Gram-positive and
Gram-negative bacteria including antibiotic resistant bacteria like
MRSA and MRSE [2,18,20].
The mechanism of the antimicrobial properties of metallic
nanoparticles is still under debate with the consensus being that
it is due to ionic contributions rather the any ‘‘nanoparticle spe-
cific’’ activity [30]. Nevertheless there has been a significant
upsurge in reports of nanomaterials exhibiting antimicrobial prop-
erties [25,21,1,15,9]. A deeper investigation reveals that many of
these reports merely append a simplistic disk diffusion assay or a
variation of this assay to essentially a material synthesis report
[26,10]. Often such studies fail to take account of the physicochem-
ical properties of the nanoparticle which have been crucially
important in helping to standardise approaches for the assessment
of nanoparticle toxicity and are likewise expected to contribute
significantly to understanding the antimicrobial properties of
nanomaterials [19,28]. In addition, limited statistical analysis is
often carried out in the aforementioned work with the inhibition
zone being taken as conclusive evidence that the nanomaterial
under study is antimicrobial with no regard to impurities, particle
coatings, competing processes or known mechanisms of interac-
tion [25,1,17].
The choice of the disk diffusion assay in these circumstances is
usually based on the fact that it is a relatively economical and easy
assay to perform, in principle. Indeed it is a common method for
testing the sensitivity of bacteria to antibiotics, which are soluble
molecules with minimal impurities. In the disk diffusion assay a
micro-organism is classed as sensitive or resistant to a material
based on the radius of the zone of inhibition which forms around
a small filter paper disk containing the test material. In comparison
to antibiotics, the properties of nanomaterials are less consistent,
with significant variations between batches in terms of particle
size distribution, bioactivity, purity and surface chemistry
[28,19]. Furthermore nano-metals such as nano-silver are often
insoluble in aqueous solution and have a tendency to agglomerate
in certain environments such as nutrient broth [19] making them
unsuitable for many assays other than the disk diffusion assay. In
addition nano-metals are also particularly efficient at forming
http://dx.doi.org/10.1016/j.jcis.2014.11.074
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metal ions in solution which are well known to exhibit antimicro-
bial properties [6]. Ion formation must be taken into account when
selecting an assay and in the interpretation of subsequent results
to distinguish the nano-particle specific effect from the ionic effect.
This is particularly true when considering particles which have
been stabilised in aqueous solvents (using coating/capping agents
such as polyvinylpyrolidone (PVP), citrate buffers or surfactants)
which will have a reduced capacity to form ions, and for
‘as-produced’ unpurified nanoparticles which will have unreacted
reducing agents present from the synthesis [25]. Considering these
aspects, a key question that this paper will address is whether or
not the disk diffusion assay is a suitable method for assessing the
antimicrobial nature of nano-metals. The paper will examine the
most appropriate approach to differentiate between the particle
and the ionic effect thereby helping to interpret the results of the
disk diffusion assay for a range of nano-silver particles, coated
and uncoated. It will also identify several pitfalls which researchers
should be aware of with respect to the processing of nanomaterials
prior to testing. The results reported reaffirm the need to charac-
terise the physicochemical properties of the nanoparticle prior to
assessing any potential antimicrobial properties analogous to the
approach taken in the emerging area of nanotoxicology [28].
Finally the relevance of the results in terms establishing protocols
for method development for ‘nanoparticle specific’ antimicrobial
properties will be discussed.
2. Materials and methods
2.1. Nanoparticles
PVP-coated silver nanopowder, particle size <100 nm was pur-
chased from Sigma Aldrich, Ireland (product number 576832).
A 20 ppm stock solution of 20 nm citrate stabilisedzed nano-silver
solution, particle size <20 nm was purchased from Sigma Aldrich
Ireland (product number 730793). The above nanoparticle prod-
ucts were used as standards, due to their high quality, monodisper-
sity and purity. As well as these, a third set of uncoated particles
were synthesised by a sodium citrate reduction of silver nitrate,
as described by Fang et al. [8]. A stock 103 M AgNO3 aqueous
solution (Sigma Aldrich, Ireland) and a stock 1% trisodium citrate
solution (Sigma Aldrich, Ireland) were prepared. 500 ml of AgNO3
aqueous solution was heated to boiling, and to this solution
10 ml of trisodium citrate solution was added drop by drop with
vigorous magnetic stirring. Heating and stirring were continued
for 30 min until a clear yellow liquid (silver nanoparticle solution)
was observed in the flask. The nanoparticle presence was con-
firmed using a Perkin Elmer Lambda 900 UV/VIS/NIR Spectrometer
to indentify the silver plasmon as discussed in previous studies
[7,26]. These in-house synthesised and commercial nanoparticles
were then characterised using multiple techniques detailed below
to estimate particle size.
2.2. Culture media
Nutrient broth was purchased from Sigma Aldrich, Ireland
(product number 70122). 25 g of nutrient broth was mixed with
1 L of deionised water before being autoclaved. Nutrient agar
was prepared by adding 15 g of bacteriological agar (Sigma Aldrich
product number A5306) to 25 g of nutrient broth before adding 1 L
of deionised water and autoclaving.
2.3. Bacterial strains
The majority of researchers use either/or Escherichia coli
and Staphylococcus aureus [25,31,21]. Therefore as an initial
representative strain, E. coli ATTC strain 25,922 was chosen and
purchased from ATCC. E. coli was taken from frozen stocks and
subcultured onto nutrient agar before being incubated at 37 C
for 24 h. This was then subcultured twice more in the same
manner before being used in experiments.
2.4. Nanoparticle characterisation
As an initial step in all nanoparticle work, it is crucial to perform
a series of physiochemical characterisation steps to establish the
nature of the particle under study [19,28]. Nanoparticles can aggre-
gate over time and in different environments, forming larger species
than may be expected (>100 nm) thereby reducing ‘‘nanoparticle-
specific’’ effects. As a result it has become good practice in nanoma-
terial laboratories to physically confirm specifications of particles
prior to use [22]. While the type of characterisation required may
vary for different particles and studies, it is expected that at a
minimum the particle size range or distribution would be deter-
mined. All particles used in this study where characterised for
size/distribution using two methods; Dynamic Light Scattering
(DLS) and Scanning Electron Microscopy (SEM). In addition particle
purity and coatings (where applicable) were confirmed using
UV–Visible absorption spectroscopy [5], X-ray diffraction spectros-
copy (XRD) [4], and atomic absorption spectroscopy (AAS) [13].
Colloidal stability was assessed using zeta potential analysis [27].
For the purpose of clarity for this paper only details of methods per-
taining to particle size distribution and were appropriate purity or
concentration will be presented and discussed.
2.4.1. Particle size distribution
Dynamic Light Scattering (DLS), also known as Photon Correla-
tion Spectroscopy, or Quasi-Electrical Light Scattering, is a non
invasive technique used to measure particle size distributions in
solvated environments, typically in the nanometer size range.
The parameter that is measured by Dynamic Light Scattering is
the hydrodynamic radius, which refers to how a particle diffuses
in a fluid [16]. Applications of DLS are typically the measurement
of particles in a liquid, e.g. proteins, polymers, micelles, nanoparti-
cles, colloidal suspensions, and emulsions [16,19].
DLS was used to establish particle size of both commercially
available and in house synthesised nano-metal samples. A Malvern
Nano series ZS Zetasizer, operating of version 7.10 of the DTS Nano
Software, was employed for all analysis. All samples were made up
to a 20 ppm concentration in deionised, ultra-pure water and mea-
sured in triplicate.
2.4.2. Particle stability
Zeta potential is the measure of the stability of a colloid system.
When particles are suspended in a media of different phase (e.g.
solids suspended in liquid) their interaction with the media sur-
rounding them determines whether the particles will coagulate
or stay dispersed. In this case, the stability of the nanoparticles
were measured both in water and in nutrient broth.
A Malvern Nano series ZS Zetasizer, operating of version 7.10 of
the DTS Nano Software, was employed for all analysis. All samples
were made up to a 20 ppm concentration in deionised, ultra-pure
water/nutrient broth and measured in triplicate.
2.4.3. Particle size and shape
Scanning Electron Microscopy (SEM) was used to determine
particle size and shape. There have been reports associating nano-
particle shape with different biological responses and so it was
deemed important to ensure that all particles in this study were
approximately the same shape (for example spherical) [24]. For
the SEM characterisation all nanoparticle samples were diluted in
ethanol, spin coated onto a cleaned silicon wafer and imaged using
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a Hitachi SU6600 FESEM SE (Secondary Electron) Detector at 5 kV
& 10 kV without coating. Multiple images were taken of each sam-
ple. The process was repeated in triplicate. Images were analysed
using ImageJ software [Branch 2008] to determine average size
and shape.
2.4.4. Concentration and purity determination
To establish the concentration of the nanoparticle suspensions
that were produced in-house, samples were analysed using a Var-
ian SpectrAA-200 atomic absorption spectrometer, and their con-
centration determined using a standard curve.
2.5. Purification of nanoparticles/ion separation
In order to purify the in-house synthesised particles and
remove any dissolved ions/impurities, nanoparticle sample was
filtered using a 10 kDa centrifugal filter unit by centrifuging at
2867g for 20 min. The retentate was then re-suspended in ultra-
pure deionised water to the desired concentration and brought
forward for testing. The supernatant was also kept for testing.
This method was also carried out on the citrate stabilised Sigma
Aldrich nanoparticle suspension and treated in the same manner.
Both the retentate and the supernatant from all of the above sam-
ples were analysed using AAS as described above to determine
particle concentration and presence of ionic impurities in the
supernatant.
2.6. The disk diffusion assay
The disk diffusion assay was first described by Bauer et al. [3].
In order to carry out this assay with nanoparticles as opposed to
traditional antibiotics the method was adapted slightly Shahaver-
di et al. [26] have previously outlined a disk diffusion method
suitable for the determination of the antimicrobial activity of
nanoparticles [26]. A modified version of this method was per-
formed here. In brief, organisms were prepared by culturing on
nutrient agar overnight. Following incubation, a standard inocu-
lum of each bacterial strain was prepared in sterile water to a
concentration of 1.5  108 CFU/ml (0.5 McFarland Standard). A
sterile swab was dipped into the suspension and then streaked
onto a pre prepared nutrient agar plate in order to provide a uni-
form coverage of bacteria on the surface of the plate. For this
experiment, all of the nanoparticle samples were tested in con-
centration ranges from 0 to 100 ppm. 40 ll of the nanoparticle
suspension was then aliquoted onto a sterile filter paper disk
(purchased from Oxoid, Ireland). The disk was then placed on
top of the surface of the plate. Numerous disks could be placed
on the same plate. All disks and plates were labelled and incu-
bated for 24 h at 37 C.
3. Results
3.1. Nanoparticle characterisation
As aforementioned, the physicochemical characterisation of
nanoparticles as exposed is a critical step in the interpretation of
biological assays and the subsequent elucidation of any ‘nanopar-
ticle-specific’ responses which may be identified. The particles in
this study have been characterised via multiple techniques, details
of the results relevant to this paper namely size distribution and
shape are presented in Table 1. The comparison to the manufac-
turer’s specification has also been given.
From Table 1, it can be seen that all measurements were in
agreement with the manufacturers specifications for the commer-
cial particles. SEM analysis did reveal a degree of aggregation in
the particles reflected by the larger mean in the particle size, which
has been attributed to the spin coating process enhancing the
potential for nanoparticle–nanoparticle interaction as the solvent
is removed, nevertheless all particles remained below the notional
100 nm barrier for nanoparticles. The largest particles were identi-
fied in the citrate coated nano-silver were a range of 46 ± 24 nm in
size was observed. Colloidal stability studies also confirmed the
aggregation of the particles in aqueous environment, being even
more pronounced in the nutrient broth. In particular with respect
to the uncoated in-house synthesised particles were clear aggrega-
tion was seen post 48 h. This however was sufficient time to per-
form any sample preparation and exposure required for the disk
diffusion assay (see Figs. 1 and 2).
3.2. Disk diffusion assay on commercially purchased particles
100 ppm stock solutions of both the citrate and PVP coated
commercial particles were prepared in deionised ultra pure water
and serially diluted for testing. 40 ll of each subsequent nanopar-
ticle suspension was then aliquoted onto the sterile filter paper
disks ready for exposure. In all experiments ampicillin was
employed as a positive control while sterile deionised water was
used as the negative control. All experiments were carried out in
triplicate. Figures below show typical results as seen in one
experiment. Table 2 shows the inhibition zone diameters for all
three sets of experiments, expressed as a mean value ± standard
deviation.
Fig. 5 shows the disk diffusion assay carried out on E. coli using
the commercial citrate stabilised nano-silver dispersion over a con-
centration range of 10–100 ppm nano-silver. The assay displayed
no inhibition zone around the disks containing the nano-silver or
the negative control (Fig. 5a left lower quadrant). This suggests
that the citrate stabilised nano-silver at concentrations up to
100 ppm has no observable antimicrobial effect on E. coli. The posi-
tive control, ampicillin did display a zone of inhibition of approxi-
mately 0.6 cm (Fig. 5a right lower quadrant).
Table 1
Relevant nanoparticle characterisation. DLS measurements were performed at a 20 ppm concentration in deionised, ultra-pure water and measured in triplicate. SEM samples
were spin coated onto silicon from ethanol and analysed in Image J software. Data is expressed as the mean ± standard deviation.
Material Particle size (nm) Particle shape Zeta potential (mV)
Manufacturer’s
specifications
DLS SEM Manufacturer’s
specifications
SEM In water In nutrient
broth
Sigma Aldrich™ citrate ctabilised nano-
silver dispersion
20 ± 4 21.04 ± 2.3 46 ± 24 Spherical Spherical 25.23 ± 5.3 7.53 ± 1.0
Sigma Aldrich™ PVP-stabilised nano-silver
powder
<100 30.8 ± 0.94 50 ± 10 Spherical Spherical 31.2 ± 0.5 8.51 ± 3.0
In house synthesised (impure) n/a 12.99 ± 1.0 40 ± 10 n/a Spherical 37.26 ± 1.4 15.66 ± 0.7
In-house synthesised (pure)-concentrated
stock
n/a 16.62 ± 1.6 40 ± 10 n/a Spherical 34.93 ± 0.9 7.9 ± 5.2
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Fig. 1. SEM image at scale bar of 1 lm showing citrate stabilised silver nanopar-
ticles as purchased dispersed in ethanol to a concentration of 10 ppm by sonication
using Ultrasonic Processor. SEM images of various silver nanoparticles, all prepared
by dispersion in ethanol followed by sonication. Samples were spin coated onto
silicon wafers before being analysed in the SEM.
Fig. 3. SEM image at scale bar of 1 lm showing impure in-house synthesised silver
nanoparticles as purchased dispersed in ethanol to a concentration of 10 ppm by
sonication using Ultrasonic Processor tip. SEM images of various silver nanopar-
ticles, all prepared by dispersion in ethanol followed by sonication. Samples were
spin coated onto silicon wafers before being analysed in the SEM.
Table 2
Results of disk diffusion assay using various types of silver nanoparticles against E. coli. Data is expressed as mean ± SD of three independent experiments.
Nanoparticle
concentration (ppm)
In-house
impure
In-house
purified
In-house supernatant
from purification
Sigma citrate
stabilised AgNP
Supernatant from sigma
citrate stabilised AgNP
Sigma PVP
stabilised AgNP
AgNO3
Diameter of zone of inhibition (cm)
0 0 0 – 0 – 0 0
10 0.4 ± 0.34 0 – 0 – 0 0
20 0.68 ± 0.1 0 – 0 – 0 0
30 0.76 ± 0.2 0 – 0 – 0 0
40 0.88 ±.027 0.93 ± 0.74 – 0 – 0 0.56 ± 0.05
50 0.94 ± 0.22 0 – 0 – 0 0.73 ± 0.04
60 1.12 ± 0.37 0 – 0 – 0 0.83 ± 0.12
70 1.13 ± 0.36 1.01 ± 0.85 – 0 – 0 0.99 ± 0.08
80 1.26 ± 0.28 0.64 ± 0.18 – 0 – 0 1.13 ± 0.03
90 1.2 ± 0.36 1.05 ± 0.35 – 0 – 0 1.05 ± 0.08
100 1.42 ± 0.23 0.98 ± 0.13 – 0 – 0 1.19 ± 0.08
Supernatant – – 1.23 ± 0.13 – 0 – –
Fig. 2. SEM image at scale bar of 2 lm showing PVP stabilised silver nanoparticles
as purchased dispersed in ethanol to a concentration of 10 ppm by sonication using
Ultrasonic Processor tip. SEM images of various silver nanoparticles, all prepared by
dispersion in ethanol followed by sonication. Samples were spin coated onto silicon
wafers before being analysed in the SEM.
Fig. 4. SEM image at scale bar of 1 lm showing purified in-house synthesised silver
nanoparticles as purchased dispersed in ethanol to a concentration of 10 ppm by
sonication using Ultrasonic Processor tip. SEM images of various silver nanopar-
ticles, all prepared by dispersion in ethanol followed by sonication. Samples were
spin coated onto silicon wafers before being analysed in the SEM.
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Fig. 6 displays the disk diffusion assay carried out on E. coli
using the commercial PVP stabilised nano-silver powder in con-
centrations ranging from 10 ppm to 100 ppm. Similar to the citrate
coated particles in Fig. 5, no inhibition zone can be identified
around disks containing the nano-silver. This indicates that the
disk diffusion does not provide any observable evidence for antimi-
crobial activity of PVP coated nano-silver towards E. coli, at concen-
trations as high as 100 ppm. The positive control, ampicillin,
displayed a visible zone of inhibition.
These results somewhat contradict many literature reports
indicating that nano-silver seemingly displays antimicrobial activ-
ity towards E. coli and other pathogenic bacteria [24,25,1]. A key
difference however is that in these reports, the particles tend to
be in-house synthesised particles which are subsequently stabi-
lised. To mimic this, a further study was performed using nanopar-
ticles synthesised as described by Fang et al. [8]. While the
mechanism of action of nano-silver is still not fully understood,
there is much evidence to suggest that the nanoparticle acts indi-
rectly on the microorganism, acting as a vehicle for the active Ag+
ions which are continuously released from the surface of the parti-
cle [30] resulting in the antimicrobial effect. It is thus proposed
here that stabilising surface coatings or capping agents such as
PVP and citrate prevent or delay the rate at which ions are released
from the surface of the nanoparticle, thereby suppressing any anti-
microbial activity. In addition the omission of clean up or purifica-
tion step in in-house nanoparticle syntheses may result in leftover
starting material (AgNO3) and ionic by-product both of which are
known to be antimicrobial. To test this hypothesis, silver nanopar-
ticles were synthesised as described previously, and tested both
before and after purification procedure in order to compare their
antimicrobial activity.
Fig. 7 shows the results of the disk diffusion assay on the in-
house synthesised nanoparticles without purification. There was
a notable antimicrobial activity in the form of inhibition zones
from particle concentrations of 30 ppm upwards. Table 2 shows
the diameters of each of the zones. There is a general trend of
increasing zone diameter with increasing particle concentration,
with the 30 ppm particles showing an average inhibition zone of
0.76 cm ± 0.2 cm, and the 100 ppm particles having an average
inhibition zone of 1.4 cm ± 0.2 cm, which is greater than that
observed for the ampicillin.
This result would seem to indicate a clear enhancement of the
antimicrobial activity in the absence of any particle capping/coat-
ing agents. However before such a statement can be made it is cru-
cial that the same study be performed for purified particles. Fig. 4
shows the activity of the in-house synthesised particles following a
purification step to remove dissolved ions left over from the start-
ing product. The nanoparticle solution was filtered using a 10 kDa
centrifugal filter unit by centrifuging at 2867g for 20 min. The
retentate was then re-suspended in ultrapure deionised water
and brought forward for testing.
Fig. 8 shows the results of the assay carried out on the purified
particles. It is evident that the purified particles are less antimicro-
bial than the impure particles in Fig. 3, with the largest average zone
diameter being 1.05 cm ± 0.35 cm compared with 1.42 cm for the
impure particles. The supernatant from the clean up step was also
assayed and this showed significant antimicrobial activity with an
average inhibition zone diameter of 1.23 cm ± 0.13 cm. Atomic
absorption spectroscopywas subsequently carried out on the super-
natant and revealed a silver ion concentration of 31.08 ppm. It can
therefore be concluded that dissolved ions and impurities present
in the in-house synthesised particles are strongly antimicrobial.
Fig. 6. Typical disk diffusion assay response for E. coli to the PVP stabilised nano-silver dispersion purchased from Sigma Aldrich. Testing was performed over the
concentration range of 10–100 ppm, shown in A, B and C. The negative control was deionised water and is shown in the left lower quadrant of A labelled (0). The positive
control was ampicillin and is shown in the right lower quadrant of A labelled (AMP).
Fig. 5. Typical disk diffusion assay response for E. coli to the citrate stabilised nano-silver dispersion purchased from Sigma Aldrich. Testing was performed over the
concentration range of 10–100 ppm, shown in A, B and C. The negative control was deionised water and is shown in the left lower quadrant of A labelled (0). The positive
control was ampicillin and is shown in the right lower quadrant of A labelled (AMP) .
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Fig. 8 therefore suggests that in the case of in-house synthesised
particles, it is possible that there is a contribution to the antimicro-
bial activity due to impurities in the form of left over starting prod-
uct in the sample. However, the uncoated particles do display
antimicrobial activity over a range of concentrations, whereas the
Sigma Aldrich™ citrate coated nanoparticles displayed no antimi-
crobial effect at these concentrations.
In order confirm the theory that antimicrobial activity of insuf-
ficiently cleaned nanoparticles is due to impurities, the starting
product (silver nitrate) was also tested for antimicrobial activity.
The results are shown in Fig. 9. It can be seen that inhibition zones
are caused at concentrations of 40 ppm upwards, with the 100 ppm
particles displaying an average zone diameter of 1.19 cm ± 0.08 cm.
This is comparable to the results seen for the impure particles,
which againwould suggest that the activity seen by the impure par-
ticles may be mostly induced by remnant silver nitrate.
The supernatant from the purification step carried out on the
Sigma Aldrich™ citrate coated particles was also tested for antimi-
crobial activity. According to the manufacturer, there should min-
imum ionic by-product in the supernatant. This was verified using
atomic absorption spectroscopy, which revealed a maximum silver
ion concentration of 1.48 ppm. This low concentration of ions is to
be expected due to the fact that the citrate coated particles have
been shown to display poor antimicrobial activity, due to their
inefficiency at releasing ions. Fig. 10 shows that the supernatant
of the Sigma Aldrich™ citrate coated nanoparticles does not have
any antimicrobial activity due to the reduced level of ionic silver
present in the sample. This is expected as the dispersion is of very
high purity and it has already been observed that the citrate coated
particles are not antimicrobial, due to the fact that they are not
efficient at releasing ions. While the presence of silver species
had previously been detected using AAS (detailed above), as a
Fig. 7. Typical disk diffusion assay response for E. coli to the in-house synthesised uncoated silver nanoparticles before purification. Concentrations range from 100 ppm
down to 10 ppm, shown in A, B and C. The negative control was deionised water and is shown in the left lower quadrant of A labelled (0).
Fig. 8. Typical disk diffusion assay response for E. coli to in-house synthesised uncoated silver nanoparticles after purification. Concentrations range from 100 ppm down to
10 ppm, shown in A, B and C. The negative control was deionised water and is shown in the left lower quadrant of A labelled (0). The supernatant from the cleanup step was
also assayed and shown in d.
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further test, the supernatants from both the Sigma Aldrich™ parti-
cles and the in-house synthesised particles were tested for the
presence of silver ions by the addition of a chelating agent, NaCl.
The presence of silver ions in solution would result in the appear-
ance of a cloudy precipitate on the addition of NaCl as the ions
react with it to form silver chloride. It was noted that the addition
of NaCl to the in-house nanoparticle supernatant resulted in the
formation of a precipitate, indicating the presence of silver ions,
while no precipitate was formed by the Sigma Aldrich™ citrate
stabilised nanoparticle supernatant, providing confirmation of
the absence of ions in the supernatant of the commercial silver
nanoparticles.
Silver nanoparticles are thought to release ions from their sur-
face, which is dependent on dissolved oxygen [14],[12]. In order
to test the ability of silver nanoparticles to release ions in an agar
based medium, the dissolved oxygen content of the nutrient agar
was measured over the time it took for it to solidify. This was then
compared to the dissolved oxygen content of nutrient broth which
is used in the formulation of the agar.
Dissolved oxygen (DO) concentration was measured using a
Vernier™ Dissolved Oxygen Probe over a time period of 0–2500 s
(to allow the agar to fully solidify). Results showed a marked
difference in dissolved oxygen concentration between the broth
(7 ppm DO) and agar (5 ppm DO) at the beginning of the experi-
ment, while at 2500 s, the level of dissolved oxygen in the agar
had fallen to 3.5 ppm while levels in the broth remained consis-
tently in the range of 6 to 7 ppm. While more work would need
to be carried out to ensure that changes in DO can cause an effect
on ion production, it seems to indicate that carrying out antimicro-
bial activity assays in agar based media hinders the ability of silver
nanoparticles to release ions and hence induce an antimicrobial
effect.
4. Discussion
The promise of metal nanoparticles as new emerging antimicro-
bials is undoubtedly an exciting prospect, with significant benefits
and commercial potential. Nano-silver in particular has been the
focus of much attention with numerous consumer products claim-
ing antimicrobial properties derived from nano-silver [29]. This is
despite reports indicating that nano-silver has negligible antimi-
crobial properties and that it is the silver ion which is the source
of the antimicrobial effect. Indeed the results presented in this
paper have shown that the antimicrobial activity of silver nanopar-
ticles can vary significantly depending on the physiochemical
characteristics of the particle and that the these properties are
dependent on the synthesis and processing of the nanomaterial
prior to performing any antimicrobial assay. Three silver nanopar-
ticles particles were assessed in this paper against E. coli; two
commercially purchased and stabilised particles and one in-house
synthesised particle. The in-house particle was tested in its as-
produced state and in a purified state. The disk diffusion assay
was chosen as it is the most common assay used in antimicrobial
nanomaterial synthesis. The results indicated that neither of the
commercial particles displayed any zones of inhibition with
respect to E. coli. It should be noted that the manufacturer did
not claim any antimicrobial properties of their particles. In contrast
the in-house synthesised particle as-produced did display zones
between 0.4 cm and 1.42 cm for the concentration range 10–
100 ppm respectively. However once the particle was purified,
these zones were seen to decrease. The removed product from
the purification step (supernatant) however exhibited comparable
zones to the impure material. This supernatant product was shown
to contain up to 31.08 ppm of ionic silver which is a known to
induce an antimicrobial effect. In addition residual un-reacted
starting products such as silver nitrate are also expected to be pres-
ent and itself can cause an antimicrobial effect. The results
reported here highlight the need for an awareness of the nature
of the material under test. This is very much in agreement with
the findings Xiu et al. [30] who first reported observing no direct
Fig. 9. Typical disk diffusion assay response for E. coli to silver nitrate in comparable concentrations of 100 ppm to 10 ppm, shown in A, B and C. The negative control was
deionised water and is shown in the left lower quadrant of A labelled (0). The positive control was ampicillin and is shown in the right lower quadrant of A labelled (AMP).
Fig. 10. Typical disk diffusion assay response for E. coli to the resultant supernatant
from the purification process of the Sigma Aldrich™ citrate coated particles.
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antimicrobial effects of nano-silver but rather attributed the effect
to ionic silver. Despite this, there are still reports emerging which
present the antimicrobial activity of silver nanoparticles with no
regard to the potential presence of the ion or other impurities.
Sadeghi et al. [25] reported zones of inhibition of 2 mm for S.
aureus and 1 mm for E. coli using silver nanoparticles synthesised
by the borohydride reduction method at a concentration of around
5 ppm. However, no attempt to clean the particles after synthesis is
evident [25]. Maneerung et al. [17] again used the disk diffusion
assay to test nanoparticle-impregnated cellulose against S. aureus
and E. coli. In this case, the samples used for the disk diffusion
assay had been freeze dried, but all characterisation of the nano-
composite had been carried out before freeze drying. Hence it is
not clear whether the freeze drying may affect the morphology
of the particles, and/or remove ionic impurities from the sample.
No antimicrobial assay before freeze drying was evident in the
study [17].
The results presented here are not intended to contradict or
undermine such reports but serve as a reminder of the importance
of considering the physicochemical properties of the nanomaterial,
a lesson which was learned by the nanotoxicology community in
recent years, and applies to in-house synthesised particles pre-
dominantly. Such particles present challenges in determining the
degree of coverage of coating or stabilising agents and may contain
impurities in the form of ionic by-product and starting material.
In demonstrating the negligible particle specific antimicrobial
behaviour of silver nanoparticles Xiu et al. [30] also found that sil-
ver nanoparticles which had been synthesised, stored and assessed
anaerobically could not release ions on exposure to E. coli, verifying
the active role of the ionic form of silver. The result indicated that
oxidation of the particles caused release of silver ions, which
increased the antimicrobial effect. In aerobic conditions several
studies have suggested that the concentration of dissolved oxygen
in solution has an impact on the dissolution rate of the ions from
silver nanoparticles [14,12]. These studies suggest that dissolved
oxygen in solution aids the surface oxidation of silver nanoparti-
cles leading to ion release. Hence the higher the concentration of
dissolved oxygen in solution, the higher the dissolution rate of
the ions. This is reflected in the result presented in this paper
where a decrease in the DO was identified in solidified agar in com-
parison to nutrient broth (3.5 ppm DO and 7 ppm DO respectively).
As the mechanism of action of metallic nanoparticles is thought to
be dependent on dissolved oxygen present in the surrounding
media, it has been assumed that the antimicrobial activity
observed in the agar for the disk diffusion assay is directly influ-
enced by the local dissolved oxygen concentration. In addition, as
the ionic species are released from the particle, their mobility
would be reduced in agar as opposed to a liquid medium. It must
be noted that the release of ions is not solely dependent on dis-
solved oxygen, but in the case of the commercial nano-silver stud-
ied here, the coating has a significant influence on the ability of the
particle to release ions. Capping agents such as sodium citrate and
PVP are often used in the synthesis of silver nanoparticles to create
smaller and more stable particles. In theory the capping agent sur-
rounds the surface of the particles and therefore it may hinder ion
release. In a static test system such as agar, this effect could be
even more pronounced.
These findings, combinedwith the findings of Xiu et al. therefore
highlight an issue which underpins many of the obstacles faced in
nanoparticle antimicrobial activity assays; the synthesis route by
which the nanoparticle is produced, and subsequently the particle
morphology and physiochemical characteristics can have a pro-
found effect on the activity of that particle. This once again stresses
the need for careful consideration of particle choice as well as the
need for thorough physiochemical characterisation when evaluat-
ing antimicrobial activity. The consideration therefore should not
be whether the assay method is applicable to nanomaterials but
whether the particle itself is suitable for the assay. To determine
the suitability of a particle for an assay and to allow for inter-
laboratory reproducibility, it is proposed here that as a precursor
to any antimicrobial studies, a series of prioritised characterisation
steps for the particle be considered. It is proposed that the following
characterisation steps are key, based on the findings of this paper
and those of Xiu et al. [30]:
 Confirmation of particle coatings or stabilising agents.
 Detailed breakdown of synthesis route and potential
impurities.
 Size and shape characterisation in order to assess size depen-
dent contributions.
 Presence of competing or complimentary process in the
media, such as dissolved oxygen.
 The rate of ion dissolution and mobility for metallic
nanoparticles.
In summary this study raises a number of issues about the anti-
microbial assessment of nanoparticles, in particular with regard to
material handling prior to performing an antimicrobial assess-
ment. Ensuring that the nanoparticle is appropriately characterised
will ensure reproducibility between nanoparticle batches and
more importantly in inter-laboratory tests and for regulatory pur-
poses. The later aspect is important when considered alongside the
increasing number of nanoparticle based consumer products
claiming to be antimicrobial. The increasing demand on research
to demonstrate commercial relevance has led many material
synthesis researchers to use basic antimicrobial studies to demon-
strate a potential real-world application of newly synthesised par-
ticles and in the absence of standardised approaches, the transition
from research laboratory to consumer products is becoming all too
easy. In addition without truly understanding the nature of the
material being assessed, the elucidation of any potential mecha-
nism becomes impossible. It is hoped therefore that this report will
open the debate on how best to approach and standardise the anti-
microbial testing of nanomaterials.
5. Conclusion
This paper examined the appropriateness of the disk diffusion
assay as an approach to assess the antimicrobial properties of
nanoparticles, namely a selection of coated and uncoated nanosil-
ver particles. The work demonstrated that for nanomaterials, the
assay results are very much dependent on understanding the
physicochemical characteristics of the nanoparticle and the poten-
tial antimicrobial mechanism of interaction. For the disk diffusion
assay it was shown that coated and purified particles showed min-
imal antimicrobial activity. In comparison ionic silver present in
the as-produced in-house synthesised particles showed zones of
inhibition as large as 1.7 cm. The result highlights that when
selecting an assay it is crucially important to appropriately charac-
terise the nanoparticle and ensure that the characterisation is fully
integrated into the methodology of the assay. The relevance of the
results in terms establishing protocols for method development for
‘nanoparticle specific’ antimicrobial properties was also discussed.
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